OPKO Health Price to Free Cash Flow Ratio 2010-2024 | OPK
Historical price to free cash flow ratio values for OPKO Health (OPK) since 2010.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
| OPKO Health Price to Free Cash Flow Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM FCF per Share | Price to FCF Ratio |
| 2024-12-05 | 1.57 | 0.00 | |
| 2024-09-30 | 1.49 | $-0.21 | 0.00 |
| 2024-06-30 | 1.25 | $-0.12 | 0.00 |
| 2024-03-31 | 1.20 | $-0.08 | 0.00 |
| 2023-12-31 | 1.51 | $-0.06 | 0.00 |
| 2023-09-30 | 1.60 | $-0.06 | 0.00 |
| 2023-06-30 | 2.17 | $-0.15 | 0.00 |
| 2023-03-31 | 1.46 | $-0.16 | 0.00 |
| 2022-12-31 | 1.25 | $-0.16 | 0.00 |
| 2022-09-30 | 1.89 | $-0.13 | 0.00 |
| 2022-06-30 | 2.53 | $0.07 | 38.80 |
| 2022-03-31 | 3.44 | $0.06 | 53.33 |
| 2021-12-31 | 4.81 | $0.14 | 33.20 |
| 2021-09-30 | 3.65 | $0.25 | 14.80 |
| 2021-06-30 | 4.05 | $0.07 | 62.31 |
| 2020-12-31 | 3.95 | $0.01 | 0.00 |
| 2020-09-30 | 3.69 | $-0.37 | 0.00 |
| 2020-06-30 | 3.41 | $-0.43 | 0.00 |
| 2020-03-31 | 1.34 | $-0.43 | 0.00 |
| 2019-12-31 | 1.47 | $-0.45 | 0.00 |
| 2021-03-31 | 4.29 | $-0.20 | 0.00 |
| 2019-09-30 | 2.09 | $-0.30 | 0.00 |
| 2019-06-30 | 2.44 | $-0.31 | 0.00 |
| 2019-03-31 | 2.61 | $-0.26 | 0.00 |
| 2018-12-31 | 3.01 | $-0.24 | 0.00 |
| 2018-09-30 | 3.46 | $-0.19 | 0.00 |
| 2018-06-30 | 4.70 | $-0.22 | 0.00 |
| 2018-03-31 | 3.17 | $-0.24 | 0.00 |
| 2017-12-31 | 4.90 | $-0.23 | 0.00 |
| 2017-09-30 | 6.86 | $-0.17 | 0.00 |
| 2017-06-30 | 6.58 | $-0.14 | 0.00 |
| 2017-03-31 | 8.00 | $-0.01 | 0.00 |
| 2016-12-31 | 9.30 | $0.03 | 347.01 |
| 2016-09-30 | 10.59 | $-0.04 | 0.00 |
| 2016-06-30 | 9.34 | $-0.09 | 0.00 |
| 2016-03-31 | 10.39 | $-0.26 | 0.00 |
| 2015-12-31 | 10.05 | $0.31 | 32.03 |
| 2015-09-30 | 8.41 | $0.26 | 32.11 |
| 2015-06-30 | 16.08 | $0.32 | 49.49 |
| 2015-03-31 | 14.17 | $0.47 | 29.85 |
| 2014-12-31 | 9.99 | $-0.14 | 0.00 |
| 2014-09-30 | 8.51 | $-0.13 | 0.00 |
| 2014-06-30 | 8.84 | $-0.06 | 0.00 |
| 2013-12-31 | 8.44 | $-0.17 | 0.00 |
| 2013-09-30 | 8.81 | $-0.12 | 0.00 |
| 2013-06-30 | 7.10 | $-0.12 | 0.00 |
| 2013-03-31 | 7.63 | $-0.15 | 0.00 |
| 2012-12-31 | 4.81 | $-0.12 | 0.00 |
| 2014-03-31 | 9.32 | $-0.13 | 0.00 |
| 2012-09-30 | 4.18 | $-0.10 | 0.00 |
| 2012-06-30 | 4.60 | $-0.10 | 0.00 |
| 2012-03-31 | 4.73 | $-0.09 | 0.00 |
| 2011-12-31 | 4.90 | $-0.07 | 0.00 |
| 2011-09-30 | 4.33 | $-0.05 | 0.00 |
| 2011-06-30 | 3.69 | $-0.06 | 0.00 |
| 2011-03-31 | 3.73 | $-0.08 | 0.00 |
| 2010-12-31 | 3.67 | $-0.08 | 0.00 |
| 2010-09-30 | 2.24 | $-0.09 | 0.00 |
| 2010-06-30 | 2.26 | $-0.08 | 0.00 |
| 2010-03-31 | 1.98 | $-0.07 | 0.00 |
| 2009-12-31 | 1.83 | $-0.10 | 0.00 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $1.085B | $0.864B |
| OPKO Health, Inc engages in the diagnostics and pharmaceuticals business in the United States, Ireland, Chile, Spain, Israel and Mexico. The Diagnostics segment operates Bio-Reference Laboratories, a clinical facility that offers testing services in the detection, diagnosis, evaluation, monitoring and treatment of diseases. The company's pharmaceutical business features Rayaldee, an FDA-approved treatment for secondary hyperparathyroidism (SHPT) in adults with stage 3 or 4 chronic kidney disease (CKD) and vitamin D insufficiency and VARUBI for chemotherapy induced nausea and vomiting. OPKO Health has a development and commercial supply pharmaceutical unit in Ireland along with a global supply chain operation and holding wing. The company also owns specialty active pharmaceutical ingredients (APIs) manufacturer in Israel. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $202.480B | 24.70 |
| Intuitive Surgical (ISRG) | United States | $196.045B | 102.50 |
| Alcon (ALC) | Switzerland | $42.794B | 28.63 |
| Edwards Lifesciences (EW) | United States | $42.188B | 26.79 |
| IQVIA Holdings (IQV) | United States | $36.777B | 20.26 |
| IDEXX Laboratories (IDXX) | United States | $35.676B | 42.01 |
| DexCom (DXCM) | United States | $30.357B | 45.72 |
| Waters (WAT) | United States | $22.803B | 33.72 |
| STERIS (STE) | Ireland | $21.310B | 24.53 |
| SONOVA HOLDING (SONVY) | Switzerland | $20.157B | 0.00 |
| Hologic (HOLX) | United States | $17.098B | 18.47 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $14.119B | 14.49 |
| Sysmex ADR (SSMXY) | Japan | $13.255B | 0.00 |
| Globus Medical (GMED) | United States | $11.345B | 28.73 |
| Penumbra (PEN) | United States | $9.105B | 89.18 |
| Masimo (MASI) | United States | $9.091B | 43.99 |
| Teleflex (TFX) | United States | $8.576B | 13.68 |
| Glaukos (GKOS) | United States | $7.735B | 0.00 |
| PROCEPT BioRobotics (PRCT) | United States | $4.949B | 0.00 |
| Integer Holdings (ITGR) | United States | $4.675B | 26.50 |
| Veracyte (VCYT) | United States | $3.420B | 102.63 |
| Inari Medical (NARI) | United States | $2.990B | 0.00 |
| LivaNova (LIVN) | United Kingdom | $2.699B | 15.58 |
| Nihon Kohden (NHNKY) | Japan | $2.361B | 17.93 |
| TransMedics (TMDX) | United States | $2.291B | 72.62 |
| Elekta AB (EKTAY) | Sweden | $2.165B | 19.47 |
| Tandem Diabetes Care (TNDM) | United States | $1.978B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $1.860B | 9.72 |
| RxSight (RXST) | United States | $1.739B | 0.00 |
| Alphatec Holdings (ATEC) | United States | $1.365B | 0.00 |
| Artivion (AORT) | United States | $1.243B | 82.39 |
| Pulse Biosciences (PLSE) | United States | $1.215B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.849B | 14.43 |
| Paragon 28 (FNA) | United States | $0.840B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.712B | 0.00 |
| IRadimed (IRMD) | United States | $0.687B | 37.11 |
| Mesa Laboratories (MLAB) | United States | $0.674B | 15.88 |
| AxoGen (AXGN) | United States | $0.656B | 0.00 |
| SiBone (SIBN) | United States | $0.567B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.561B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.556B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.512B | 30.12 |
| Treace Medical Concepts (TMCI) | United States | $0.494B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.439B | 23.75 |
| Delcath Systems (DCTH) | United States | $0.380B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.372B | 0.00 |
| NeuroPace (NPCE) | United States | $0.337B | 0.00 |
| CVRx (CVRX) | United States | $0.327B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.284B | 0.00 |
| Inogen (INGN) | United States | $0.226B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.210B | 0.00 |
| Accuray (ARAY) | United States | $0.202B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.196B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.174B | 0.00 |
| Nevro (NVRO) | United States | $0.157B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.153B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.145B | 15.49 |
| Spectral Diagnostics (EDTXF) | Canada | $0.105B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.095B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.092B | 0.00 |
| LENSAR (LNSR) | United States | $0.089B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.081B | 0.00 |
| InspireMD (NSPR) | Israel | $0.080B | 0.00 |
| 908 Devices (MASS) | United States | $0.080B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.077B | 0.00 |
| Covalon Technologies (CVALF) | Canada | $0.073B | 0.00 |
| Hyperfine (HYPR) | United States | $0.071B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.054B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.050B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.045B | 0.00 |
| Envoy Medical (COCH) | United States | $0.045B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.040B | 0.00 |
| Spectral AI (MDAI) | United States | $0.039B | 0.00 |
| Neuronetics (STIM) | United States | $0.039B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.033B | 0.00 |
| Precision Optics (POCI) | United States | $0.032B | 0.00 |
| DarioHealth (DRIO) | United States | $0.026B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.024B | 0.00 |
| NexGel (NXGL) | United States | $0.024B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.017B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.016B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.015B | 0.00 |
| Aspira Women's Health (AWH) | United States | $0.013B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.012B | 0.00 | |
| QT Imaging Holdings (QTI) | United States | $0.011B | 0.00 |
| PAVmed (PAVM) | United States | $0.011B | 0.00 |
| T2 Biosystems (TTOO) | United States | $0.011B | 0.00 |
| Tenon Medical (TNON) | United States | $0.007B | 0.00 |
| Nuwellis (NUWE) | United States | $0.006B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.005B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.005B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.005B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.004B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.003B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.003B | 0.00 |
| Avinger (AVGR) | United States | $0.003B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.002B | 0.00 |
| Venus Concept (VERO) | Canada | $0.002B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |